Ashley Waring

[MUSC Health @MUSChealth]

MUSC Health Cardiologist Dr. Ashley Waring recently joined News 2 to talk about #GoRedForWomen + the importance of women’s heart health and the symptoms that shouldn't be ignored. #ChangingWhatsPossible

@AmericanHeartSC❤️

[American Heart Association - SC @AmericanHeartSC]

Thank you Dr. Ashley Waring of @MUSChealth for joining us on @wcbd to talk about Go Red for Women and why we are raising awareness that cardiovascular disease is the No. 1 killer of women. Learn more about Go Red for Women in Charleston by visiting https://t.co/QGpH89IEke

[Eugenia Gianos MD @EugeniaGianos]

🫀#ACC25 was a blast!⭐️For an engaging recap of the core trials, join us on Wed, April 9 @ 1PM ET via the link below. Top science & experts🤓Dr. Vijay Nambi, Kausik Ray MD FMedSci, @DrEugeneYang Dr. Ashley Waring, @Nishant_ShahMD @DrSafarova
https://t.co/iFGqwa5ub9

[Ashley Waring @AWaringCardio]

Congratulations to our medical student, Ciara Armstrong, and her poster at ACC.25 on FH patients and an APO B variant! @MUSCCardFellows

[MUSC Cardiology Fellowship Programs @MUSCCardFellows]

MUSC Cardiology holding it down strong at #ACC25 @ACCinTouch 💪💪🫀🫀

[Eugenia Gianos MD @EugeniaGianos]

apologies- this is the correct link to register! 👉 https://t.co/iFGqwa5ub9

[Eugenia Gianos MD @EugeniaGianos]

Join our @ACCInTouch #ACCPrevCouncil Wed, 9/11 @noon as our #CVPrev experts recap ACC.24 & its influence on our practice.
REG➡️ https://t.co/tmUlyTyTjV⬅️ #ACCFIT @EugeniaGianos @DrEugeneYang @AWaringCardio @Nishant_ShahMD Dr. Vijay Nambi, Dr Joseph Ebinger

[Ashley Waring @AWaringCardio]

Late breaking trial session yesterday at #ACC24 chaired by MUSC’s Dr Pam Morris (far left). Trials show promising results for new injectable prevention meds: zilebesiran (HTN), olezarsen (TGs), lerodalcibep (LDL), plozasiran(TGs).
@MUSC_WIC @MUSC_Cardiology @MUSChealth

[Ashley Waring @AWaringCardio]

Excited for day one of ACC.24!

[Ashley Waring @AWaringCardio]

Check out my brief podcast on Women’s Heart Health on SC NPR! https://t.co/Lhk1dZmVos